WordNet
- a nonmetallic univalent element belonging to the halogens; usually a yellow irritating toxic flammable gas; a powerful oxidizing agent; recovered from fluorite or cryolite or fluorapatite (同)F, atomic number 9
- the 6th letter of the Roman alphabet (同)f
PrepTutorEJDIC
- フッ素(化学記号はF)
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 骨髄炎の疑いがある状況での画像検査法 approach to imaging modalities in the setting of suspected osteomyelitis
- 2. 肺サルコイドーシスの臨床症状および診断 clinical manifestations and diagnosis of pulmonary sarcoidosis
- 3. 頭頸部扁平上皮癌における、 化学放射線療法併用または非併用下での根治的放射線療法後の頸部のマネージメント management of the neck following definitive radiotherapy with or without chemoradiotherapy in head and neck squamous cell carcinoma
- 4. 心臓埋め込み型電気デバイスの感染 infections involving cardiac implantable electronic devices
- 5. 冠動脈疾患の核イメージングによる心筋生存能の評価 assessment of myocardial viability by nuclear imaging in coronary heart disease
English Journal
- Current status and future challenges of brain imaging with 18F-DOPA PET for movement disorders.
- Calabria FF1, Calabria E, Gangemi V, Cascini GL.
- Hellenic journal of nuclear medicine.Hell J Nucl Med.2016 Mar 1. pii: s002449910335. [Epub ahead of print]
- OBJECTIVE: Parkinson's disease (PD) is a neurodegenerative disorder (ND) due to progressive loss of dopaminergic neurons in the basal ganglia. The correct differential diagnosis of this disease with parkinsonian syndromes (PS) or with essential tremor (ET) is a diagnostic dilemma, considering that o
- PMID 26929938
- A prospective trial of dynamic contrast-enhanced MRI perfusion and fluorine-18 FDG PET-CT in differentiating brain tumor progression from radiation injury after cranial irradiation.
- Hatzoglou V1, Yang TJ1, Omuro A1, Gavrilovic I1, Ulaner G1, Rubel J1, Schneider T1, Woo KM1, Zhang Z1, Peck KK1, Beal K1, Young RJ1.
- Neuro-oncology.Neuro Oncol.2015 Dec 19. pii: nov301. [Epub ahead of print]
- BACKGROUND: The aim of this study was to assess the effectiveness of fluorine-18 fluorodeoxyglucose (FDG) PET-CT and dynamic contrast-enhanced (DCE) MRI in differentiating tumor progression and radiation injury in patients with indeterminate enhancing lesions after radiation therapy (RT) for brain m
- PMID 26688076
- Comparison of 18F-fluorodeoxyglucose PET/CT findings with vascular endothelial growth factors and receptors in colorectal cancer.
- Kocael A1, Vatankulu B2, Şimşek O1, Cengiz M3, Kemik A4, Kocael P1, Halaç M5, Sönmezoğlu K5, Ulualp K1.
- Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.Tumour Biol.2015 Oct 17. [Epub ahead of print]
- The purpose of this study was to evaluate the association of 18F-fluorodeoxyglucose (FDG)-PET/CT findings with the vascular endothelial growth factor (VEGF) family and its receptor (VEGFR) levels in metastatic and nonmetastatic colorectal cancer (CRC). Fluorine-18 FDG-PET/CT scans were performed for
- PMID 26476536
Japanese Journal
- 腹腔鏡下脾臓摘出術を施行した脾原発炎症性筋線維芽細胞性腫瘍の1例
- 日本消化器外科学会雑誌 47(10), 602-607, 2014
- NAID 130004697444
- Findings of fluorine-18-FDG PET in extranodal origin lymphoma : In three cases of diffuse large B cell type lymphoma
- Annals of nuclear medicine 20(10), 689-693, 2006-12-01
- NAID 10031135834
- An abnormal accumulation of fluorine-18-FDG PET in cytomegalovirus enteritis-A case report
- Annals of nuclear medicine 20(1), 75-78, 2006-01-01
- NAID 10018777005
Related Links
- Background and Purpose. Several studies have evaluated the role of fluorine-18-fluorodeoxyglucose positron emission tomography and positron emission tomography/computed tomography (FDG-PET and PET/CT) in ...
- External Radiation The specific gamma ray constant for fluorine F 18 is 6.0 R/hr/mCi (0.3 Gy/hr/kB) at 1cm. The half-value layer (HVL) for the 511 keV photons is 4.1 mm lead (Pb). A range of values for the attenuation of radiation ...
Related Pictures
★リンクテーブル★
| リンク元 | 「18F-FDG」 |
| 関連記事 | 「F」「FDG」 |
「18F-FDG」
- 英
- 18F-fluorodeoxyglucose, fluorine-18-FDG, fluorine 18 fluorodeoxyglucose, 18-Fluoro-2-Deoxyglucose
- 同
- フッ素18-FDG、18FDG
- 関
- 放射性医薬品、フルオロデオキシグルコース FDG
-18FDG